Ê×Ò³| Â鶹´«Ã½Ó³»­

Cognoptix, a leading diagnostics company dedicated to early detection of Alzheimer's disease (AD), announced today the formation of its new Scientific Advisory Board (SAB) with appointment of five world-class scientists and clinical researchers in AD. The SAB includes Jeffrey L. Cummings, MD, ScD; Lee E. Goldstein, MD, PhD; Philip Scheltens, MD, PhD; Martin R. Farlow, MD; and Carl H. Sadowsky, MD. Drs. Cummings and Goldstein will serve as SAB Clinical and Science Chairs, respectively.

Whether you have your own home office or are using a laptop at your kitchen table, if you’re one of the many Canadians who are working from home, you know how important a comfortable setup can be.

A new Chinese therapy for Alzheimer’s is embarking on a much-anticipated U.S. study -- the latest bid to revive hopes in the multibillion-dollar search for an effective medicine against the incurable disease.

Which foods do you need to eat as you strengthen your muscles? Foods rich in protein give you fuel for muscle-building workouts, but experts say you need a variety of other nutrients like carbohydrates, fiber, and healthy fats too.

A Chinese-German team of researchers, using data from the Lunar Lander Neutrons and Dosimetry (LND) experiment onboard China’s Chang’e 4 lander on the Moon’s far side, has obtained the first-ever comprehensive radiation measurements from the Moon’s surface.

EIP Pharma, Inc. (), a CNS-focused therapeutics company, today announced that the Phase 2 AscenD-LB study in patients with mild-to-moderate dementia with Lewy bodies (DLB) met its primary endpoint of demonstrating an improvement in cognition as assessed by the Neuropsychological Test Battery (NTB). In the double-blind placebo-controlled study, patients receiving neflamapimod three times daily (TID) demonstrated significant improvement on the NTB compared to those who received either placebo or neflamapimod twice daily (BID); p=0.015, effect size (Cohen's d)=0.52. In addition, statistically significant improvements (p<0.05) or trends (p<0.1) were evident on multiple secondary clinical endpoints. The full results have been accepted as a late-breaking abstract and will be shared on November 7, 2020 during an oral presentation at the 13th Clinical Trials in Alzheimer's Disease (CTAD) meeting.

A champion for brain heath, a trail blazer for innovative research and a passionate advocate for women supporting women, Dr. Zhong is engaged in the southern Nevada community.

Researchers are working to find new ways to protect the human body from radiation in space in order to allow people to live far from Earth for years at a time.

Ê×Ò³| Â鶹´«Ã½Ó³»­ ten million U.S. adults are vegan or vegetarian. Unfortunately, it’s not the easiest lifestyle to adopt, as finding meatless options at restaurants and supermarkets can be a challenge. Plus, even though some experts say forgoing animal products could save you at least $750 per year, certain specialty foods can be expensive. Despite the cost, though, synthetic meat sales have received a bump this year because of meat shortages caused by the COVID-19 pandemic. Some meat eaters who switched to vegetarian or vegan options out of necessity may decide to stay once they’ve had a taste.

Moonwalkers take heart—China’s Chang’e 4 lander has made the first detailed measurements of the intense radiation that blasts the lunar surface and found that it’s safe for human exploration. The results give researchers a better idea of how much protective shielding future crews will need.

Today's Daily Dose brings you news about Gilead's acquisition of Immunomedics, Marinus' CDKL5 deficiency disorder trial results, Seattle Genetics' oncology collaborations with Merck, 89bio's NASH trial data, and Cassava Sciences' Alzheimer's trial results.

Today's Daily Dose brings you news about Gilead's acquisition of Immunomedics, Marinus' CDKL5 deficiency disorder trial results, Seattle Genetics' oncology collaborations with Merck, 89bio's NASH trial data, and Cassava Sciences' Alzheimer's trial results.